EDAP TMS S.A. Generates First U.S. Sonolith i-move Lithotripter Sale

LYON, France, Nov. 10, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced it has sold its first Sonolith i-move lithotripter in the United States to Empire Litho. The sale was recorded three months following the receipt of U.S. FDA 510(k) marketing clearance in August 2011. Empire Litho partners with hospitals and physicians to provide urological and orthopedic patient services to physicians and hospitals. Empire Litho expects to use the Sonoloth i-move on a mobile basis at its six New York City metropolitan area hospital partners.

MORE ON THIS TOPIC